BACKGROUND/AIMS: Dysphagia and odynophagia are common problems with signifi
cant morbidity in acquired immunodeficiency syndrome (AIDS) patients. Endos
copy in AIDS patients with esophageal symptoms is valuable for diagnosis, b
ut the timing and necessity of routine endoscopy remains controversial.
METHODOLOGY: We retrospectively studied 40 AIDS patients undergoing upper g
astrointestinal endoscopy. Among them, 25 patients were enroled with dyspha
gia and/or odynophagia and were put on empirical fluconazole treatment befo
re endoscopic evaluation.
RESULTS: Fourteen (56%) of 25 patients improved after fluconazole treatment
, while II patients had persistent symptoms. Among the 14 patients with sym
ptomatic improvement, 7 were found to have esophageal candidiasis which imp
roved after continuation of fluconazole for 1-2 more weeks. The other 7 pat
ients had a normal endoscopic appearance. In contrast, among II patients wi
th persistent symptoms, there were 3 patients with azole-resistant candidia
sis, 3 with cytomegalovirus esophagitis, 1 with herpes simplex virus esopha
gitis with candidiasis, 1 with Kaposi's sarcoma, and 3 with idiopathic esop
hageal ulcer. They were successfully treated with Amphotericin B, Ganciclov
ir, Acyclovior, and oral steroids, except for the patient with Kaposi's sar
coma.
CONCLUSIONS: Routine endoscopy may not necessarily be indicated in every AI
DS patient with dysphagia or odynophagia. Empirical fluconazole treatment c
an improve symptoms in 50% of patients. It is only indicated when patients
have persistent symptoms after empirical treatment. With endoscopic examina
tion, etiologic agents other than common candidiasis can be determined and
the patients can thus be put on specific treatment.